Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer  by Tachibana, Masahito et al.
ErratumHuman Embryonic Stem Cells Derived
by Somatic Cell Nuclear Transfer
Masahito Tachibana, Paula Amato, Michelle Sparman, Nuria Marti Gutierrez, Rebecca Tippner-Hedges, Hong Ma,
Eunju Kang, Alimujiang Fulati, Hyo-Sang Lee, Hathaitip Sritanaudomchai, Keith Masterson, Janine Larson,
Deborah Eaton, Karen Sadler-Fredd, David Battaglia, David Lee, Diana Wu, Jeffrey Jensen, Phillip Patton,
Sumita Gokhale, Richard L. Stouffer, Don Wolf, and Shoukhrat Mitalipov*
*Correspondence: mitalipo@ohsu.edu
http://dx.doi.org/10.1016/j.cell.2013.06.042
(Cell 153, 1228–1238; June 6, 2013)
We wish to correct a number of figure-related and typographical errors that appeared in the article above. None of these errors affect
the conclusions of the paper.
In Figures 2F and S5 (upper-right), we presented two phase-contrast photos of fields of cells, correctly labeled as SCNT-derived
hESO-NT1 and IVF-derived hESO-7, respectively. These images are the same fields of cells shown in the top two images of Figure 6D;
however, in Figure 6D, we inadvertently switched the labels on the images. This re-use of the images was intentional, but we should
have indicated this in the original legend for Figure 6. We have corrected the labeling error in Figure 6D.
In Figure S6, the scatterplot presenting a comparison between biological HDF-f replicates #2 and #3 is an inadvertent duplication of
the scatterplot presenting the comparison of HDF-f replicates #1 and #3. This plot has been replaced in the figure online and is shown
below.
In Figure 1, the number of SCNT embryos for I/DMAP group (n = 51) has been corrected to 53.
In Figure 5D, the numbers of plated blastocysts for agonist and antagonist were reversed and have been corrected to agonist (n = 4)
and antagonist (n = 17).
In the Experimental Procedures, the age range of oocyte donors in the paper was listed as 23–31; however, the range has been
corrected to 23–33.
In Table S2, percentages for fused oocytes in the 10 nM TSA for 24 hr group (95.4) and for compact morula (CM) in the 5 nM TSA for
12 hr group (26.0) have been corrected to 96.3 and 28.0, respectively.
In Table S3, we incorrectly reported several figures due to errors that occurred in converting the raw patient data, from which these
values are calculated, from a file created with Mac-based software to a file in the analogous Windows-based software. The following
corrections have been made: number of oocytes in the antagonist group 11.7 ± 5.6 has been changed to 10.2 ± 4.9; number of
oocytes in the agonist group, 20.5 ± 11.9 to 16.3 ± 5.2; AMH level in the antagonist group, 2.8 ± 0.5 to 2.5 ± 0.5; AFC in the antagonist
group, 23.1 ± 7.2 to 23.2 ± 7.2; FSH dosage in antagonist group, 958.3 ± 241.7 to 966.7 ± 247.3; number of hMG ampoules in antag-
onist group, 8.5 ± 1.6 to 10.2 ± 4.2; number of hMG ampoules in agonist group, 8.8 ± 0.9 to 8.8 ± 1.0; stimulation days in antagonist
group, 8.7 ± 1.6 to 8.7 ± 0.8; and stimulation days in agonist group, 9 ± 0.8 to 9.8 ± 1.0. We have confirmed that these differences do
not affect any of the statistical conclusions originally reported.
In Table S4, short tandem repeats (STR) readings for egg donor A in D6S291 andD6S276 loci were reversed and have been corrected
to 199/209 for D6S291 and 245/249 for D6S276.
Finally, when calculating percentages of SCNT embryos that reached different stages during development, the denominator
employed in the calculation depended on the developmental stage, as explained below, and thus was not a constant number for
all calculations. Although this is the standard in the field for these calculations, it may have caused some confusion. Therefore,
we have now added the following text to the Extended Experimental Procedures to clarify the methodology for categorizing embryos
at different stages:
‘‘In Figures 1, 3, 4, 5, and S1, percentages for ‘PN’ and ‘Cleaved’ were calculated based on the numbers of successfully recon-
structed SCNT embryos provided as ‘n.’ Percentages for ‘eight-cell,’ ‘CM,’ and ‘blastocysts’ were calculated based on the number
of cleaved embryos. In Table S2, the percentage for ‘fused’ was calculated based on the initial number of oocytes. The percentage forCell 154, 465–466, July 18, 2013 ª2013 Elsevier Inc. 465
‘PN’ was calculated based on number of fused oocytes. The percentage for ‘cleaved’ was calculated based on number of PN. The
percentages for ‘eight-cell,’ ‘CM,’ and ‘blastocysts’ were calculated based on the number of cleaved embryos. An asterisk in the
graph indicates statistical significance.’’
The corrections detailed here have been incorporated into the online version of the article, and they do not alter the description of the
results or the main conclusions. We would also like to note that the Scientific Integrity Committee at Oregon Health & Science
University has carefully assessed the paper and the errors and has concluded that there is no evidence of fabrication, falsification,
or plagiarism that would warrant further inquiry or investigation into research misconduct.Figure S6. Microarray Scatterplot Analysis of Biological Replications within Each Cell Type, Related to Figure 7
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